🇺🇸 ARWR — Arrowhead Pharmaceuticals, Inc.

Salud Compra fuerte
← Volver

Precio actual

61,65 USD

Máx. histórico

2.925,00

12011 días

Split 1:10 del 17/11/2011

Caída desde máximo

-97,89%

Rango 52 semanas

37,06 – 95,49

Variación hoy

+3,56%

Cierre anterior

59,53

Rango de hoy

59,06 – 61,99

Volumen hoy

1.487.357

Peor caída histórica

-99,96%

16/12/1993 → 16/12/2016

Aún sin recuperar

Volatilidad anualizada ⓘ

231,86%

Información
Nombre completo
Arrowhead Pharmaceuticals, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
711
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
107,71 USD (puede no estar actualizado)
Primera cotización
16/12/1993
Precio actualizado
hace 4 horas
Sobre la empresa

Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. Its pipeline includes Plozasiran to reduce production of apolipoprotein C-III in Phase 3 studies; Zodasiran to reduce production of angiopoietin-like protein 3 in Phase 3 clinical trials; ARO-DIMER-PA, a dual functional RNAi molecule in a Phase 1/2a clinical trials; and ARO-PNPLA3, an investigational RNAi therapeutic in Phase 1 clinical trials. The company also develops ARO-INHBE, to reduce the hepatic expression of the INHBE gene and its secreted gene product, Activin E in Phase 1/2a clinical trials; ARO-ALK7 to silence adipocyte expression of the ACVR1C gene in Phase 1/2a clinical trials; ARO-RAGE to reduce production of the receptor for advanced glycation end products in Phase 1/2a clinical trials; and ARO-MAPT, an investigational RNAi-based therapy. In addition, it is developing ARO-C3 to reduce production of C3 in Phase 1/2a clinical trials; and ARO-CFB to reduce hepatic expression of CFB in a Phase 1/2a clinical trials. The company has collaboration and license Agreements with Glaxosmithkline Intellectual Property (No. 3) Limited; Takeda Pharmaceutical Company Limited; Amgen Inc.; and Sarepta Therapeutics, Inc. Arrowhead Pharmaceuticals, Inc. was founded in 2003 and is headquartered in Pasadena, California.

Splits Registrados en el histórico de precios
Fecha Ratio
17/11/2011 1:10
15/01/2004 1:65
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
15/09/2021 62,46 63,79 61,87 63,51 +1,58% 3,07% 472.100
14/09/2021 64,64 65,15 62,25 62,52 -2,92% 4,49% 386.300
13/09/2021 63,76 64,95 62,25 64,40 +0,64% 4,23% 483.300
10/09/2021 65,50 65,67 63,94 63,99 -1,99% 2,64% 370.400
09/09/2021 65,75 66,68 65,02 65,29 -0,85% 2,52% 311.200
08/09/2021 65,70 66,37 65,00 65,85 +0,35% 2,09% 338.400
07/09/2021 67,20 68,84 64,86 65,62 -2,86% 5,92% 515.000
03/09/2021 68,76 69,05 67,06 67,55 -2,24% 2,89% 340.300
02/09/2021 69,00 69,65 68,23 69,10 +0,89% 2,06% 371.400
01/09/2021 67,34 68,99 67,12 68,49 +2,04% 2,78% 450.400
31/08/2021 67,07 68,16 66,43 67,12 +0,42% 2,58% 417.300
30/08/2021 66,07 68,40 66,00 66,84 +1,17% 3,63% 567.000
27/08/2021 64,39 67,93 64,20 66,07 +2,98% 5,79% 707.000
26/08/2021 63,77 65,43 63,68 64,16 +0,05% 2,75% 476.800
25/08/2021 62,60 64,50 62,07 64,13 +1,89% 3,88% 402.400
24/08/2021 62,04 63,00 61,26 62,94 +1,27% 2,80% 375.100
23/08/2021 60,90 62,91 60,55 62,15 +3,70% 3,88% 585.400
20/08/2021 58,39 61,02 58,13 59,93 +2,66% 4,95% 491.100
19/08/2021 59,30 60,10 58,26 58,38 -2,33% 3,10% 440.200
18/08/2021 60,54 61,26 59,25 59,77 -1,48% 3,32% 306.200
17/08/2021 60,09 60,98 58,99 60,67 -0,10% 3,31% 495.700
16/08/2021 60,02 61,71 60,02 60,73 +0,35% 2,82% 402.400
13/08/2021 59,82 61,80 58,96 60,52 +1,22% 4,74% 554.800
12/08/2021 58,84 60,27 58,50 59,79 +1,42% 3,01% 671.100
11/08/2021 61,21 61,99 57,92 58,95 -3,69% 6,65% 1.338.200
10/08/2021 63,62 63,94 60,95 61,21 -2,50% 4,70% 674.900
09/08/2021 65,00 65,82 61,78 62,78 -3,10% 6,21% 954.000
06/08/2021 66,36 67,57 62,50 64,79 -4,79% 7,64% 1.177.700
05/08/2021 65,94 69,01 65,64 68,05 +2,92% 5,11% 714.500
04/08/2021 66,29 67,93 65,82 66,12 -0,94% 3,18% 608.300